Abstract
Three patients of coronavirus disease (COVID-19) showed the symptoms of olfactory dysfunction. Clinical characteristics and treatment were retrospective analyzed. Olfactory disorders are uncommon symptoms of COVID-19 in China. Early diagnosis and intervention are keys to the recovery of olfactory disorders. Particular attention should be devoted to olfactory dysfunction.
Keywords:
COVID-19; Olfactory dysfunction.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adolescent
-
Adult
-
Antiviral Agents / therapeutic use*
-
Betacoronavirus / drug effects
-
Betacoronavirus / pathogenicity
-
COVID-19
-
China
-
Cobicistat / therapeutic use
-
Coronavirus Infections / diagnosis
-
Coronavirus Infections / drug therapy
-
Coronavirus Infections / physiopathology*
-
Darunavir / therapeutic use
-
Female
-
Humans
-
Indoles / therapeutic use
-
Male
-
Methylprednisolone / therapeutic use
-
Olfaction Disorders / diagnosis
-
Olfaction Disorders / drug therapy
-
Olfaction Disorders / physiopathology*
-
Pandemics
-
Pneumonia, Viral / diagnosis
-
Pneumonia, Viral / drug therapy
-
Pneumonia, Viral / physiopathology*
-
SARS-CoV-2
-
Taste Disorders / diagnosis
-
Taste Disorders / drug therapy
-
Taste Disorders / physiopathology*
-
Treatment Outcome
-
Vitamin B 12 / analogs & derivatives*
-
Vitamin B 12 / therapeutic use
Substances
-
Antiviral Agents
-
Indoles
-
umifenovir
-
mecobalamin
-
Cobicistat
-
Vitamin B 12
-
Methylprednisolone
-
Darunavir